| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2878562 | The Annals of Thoracic Surgery | 2009 | 8 Pages |
Abstract
Endogenous adenosine signals through the A2AR to attenuate inflammatory and immune factors involved in BO development. Synthetic A2AR agonists may provide a novel treatment strategy to prevent BO.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Christine L. MD, Yunge MD, PhD, Irving L. MD, Mark H. MD, Victor E. PhD, Gorav MD, Joel PhD,